Viited:

1. Luger, T. et al. Topical therapy of atopic dermatitis with a focus on pimecrolimus. Journal of the European Academy of Dermatology and Venereology. 2021, 35:1505–1518.
2. Sigurgeirsson B, et al. Safety and efficacy of pimecrolimus in atopic dermatitis: a 5-year randomized trial. Pediatrics. 2015; 135: 597–606.
3. Luger, T. et al. Unmet medical needs in the treatment of atopic dermatitis in infants: An Expert consensus on safety and efficacy of pimecrolimus. Pediatr Allergy Immunol. 2021; 32:414–424.
4. Zhao Z, et al. Experts’ Consensus on the Use of Pimecrolimus in Atopic Dermatitis in China: A TCS-Sparing Practical Approach. Dermatol Ther (Heidelb). 2022; 12:933–947.

ET-ELI-2024-00008 10/2024